Venture NAV Tracker / Private company
Cognito Therapeutics Group, Inc.
Headquarters—
Founded—
Last known round—
Reported valuation—
Cross-fund comparison
Equity & warrant marks
One latest disclosed mark per fund.
| Fund | Fair value | Security / basis | Implied price / share | Mark age vs round | Methodology / filing |
|---|---|---|---|---|---|
| HTGCHercules Capital, Inc. | $182KMar 31, 2026 · source ↗ | warrantFair Value | $2.38Mar 31, 2026 · source ↗ | —Mar 31, 2026 · source ↗ | 10-Q 2026-03-31 ↗ |
Cross-fund comparison
Debt investments
One latest disclosed debt mark per fund.
| Fund | Security type / basis | Principal | Fair value | FV / principal | Rate | Maturity | Mark age vs round | Non-accrual |
|---|---|---|---|---|---|---|---|---|
| HTGCHercules Capital, Inc. | senior secured loanFair Value — Senior Secured | $4.5MMar 31, 2026 · source ↗ | $4.3MMar 31, 2026 · source ↗ | 96.2%Mar 31, 2026 · source ↗ | Prime + 2.70 %, Floor rate 9.95 %, 5.75 % Exit FeeMar 31, 2026 · source ↗ | Jan 1, 2030Mar 31, 2026 · source ↗ | —Mar 31, 2026 · source ↗ | NoMar 31, 2026 · source ↗ |
Historical marks
Reported fair value by fund
Each bar is a disclosed position-quarter.